A61L31/046

Biodegradable extravascular stent

The present invention relates to extravascular supports. In particular, to extravascular supports which are used in vein grafting. More in particular, it relates to extravascular supports which are biodegradable.

Free-standing biodegradable patch

Methods and apparatus for a free-standing biodegradable patch suitable for medical applications, especially intravascular, minimally-invasive and intraoperative surgical applications are provided, wherein the patch comprises a free-standing film or device having a mixture of a solid fibrinogen component and a solid thrombin component that, when exposed to an aqueous environment, undergoes polymerization to form fibrin. In alternative embodiments the patch may comprise a solid fibrinogen component, with or without an inorganic calcium salt component. The patch may take a non-adherent form during delivery to a target location within a vessel or tissue, and thereafter may be activated to adhere to vessel wall or tissue, and may include a number of additives, including materials to improve the mechanical properties of the patch, or one or more therapeutic or contrast agents.

WOUND DRESSING AND A METHOD FOR PRODUCING THE SAME
20190184052 · 2019-06-20 ·

The invention provides a wound dressing made by an ex vivo formed combination of fibrinogen and/or fibrin containing-liquid formulation and an oxidized cellulose (OC) backing; and use thereof.

ENGINEERED TISSUES HAVING STRUCTURAL COMPONENTS EMBEDDED THEREIN, AND METHODS OF MAKING AND USING
20190160204 · 2019-05-30 ·

This disclosure describes engineered tissues having structural components embedded therein and methods of making and using such engineered tissues having structural components embedded therein.

VASCULAR ACCESS CHANNEL AND METHODS
20240216663 · 2024-07-04 ·

An embodiment includes a vascular port comprising: first and second portions that are not monolithic with each other; wherein: (a)(i) the first portion includes a first arcuate surface to contour to a first portion of a vessel and the second portion includes a second arcuate surface to contour to a second portion of the vessel; (a)(ii) the first and second portions couple to one another around the vessel when implanted to form a central chamber that houses the vessel; (a)(iii) the first portion includes a port that includes a funnel with a funnel surface that narrows as the funnel surface approaches the central chamber; (a)(iv) the central chamber includes a central longitudinal axis and the funnel includes a central vertical axis that is orthogonal to the longitudinal axis; (a)(v) the second portion includes a hardened, non-compliant surface that intersects the vertical axis.

Protection and Delivery of Multiple Therapeutic Proteins
20190117780 · 2019-04-25 ·

Compositions are provided herein comprising a coacervate of a polycationic polymer, a polyanionic polymer, and platelet-rich plasma and/or serum, or a fraction or concentrate thereof. The composition is useful in wound healing. Compositions also are provided that comprise a hydrogel comprising TIMP-3; and a complex of a polycationic polymer, a polyanionic polymer, FGF-2 and SDF-1 embedded in the hydrogel, which is useful in treating a myocardial infarction.

JOINT DEVICE AND METHOD
20190110896 · 2019-04-18 ·

A mould adapted to be introduced into a joint of a human patient for resurfacing at least one carrying contacting surface of said joint is provided. The mould is adapted to receive material for resurfacing at least one carrying contacting surface of said joint. The mould is further adapted to be resorbed by the human body or melt after having served its purpose.

Hydrophilic electrospinning biological composite stent material used for tissue regeneration and preparation method and application thereof

A hydrophilic electrospinning biological composite scaffold material used for tissue regeneration and a preparation method and an application thereof are provided. Fibrinogen, L-arginine or an aqueous solution of hydrochloride thereof and a P(LLA-CL) solution are blended and an electrospinning technology is used to prepare the biological composite scaffold material. The biological composite scaffold material has an equilibrium contact angle that is less than 55, is hydrophilic and has a good application prospect in repairing body tissue defects.

Composite gel for removing residual stone fragments after lithotripsy

A composition gel for surgical efficiency improvement of urinary stone lithotripsy and stone fragments removal in renal collecting system includes component A and component B. The component A contains fibrinogen and fibrin stabilizing factors. The component B contains thrombin. Moreover, at least one of the components A and B contains Ca.sup.2+, plasminogen and a coloring agent. The composition gel may quickly form plasminogen-containing fibrin gel with color, and certain toughness and plasticity in urine and normal saline environments, may adhere to and wrap stone fragments in such environments, and is removed by negative pressure suction and/or stone basket. The composition gel is suitable for efficiently removing stone fragments which remain after lithotripsy and are unable to be removed by an effective method at present. It has good biosafety, and achieves stone clearance rate of more than 85% without damage to the kidney and surgical instruments. The fibrin gel may be naturally dissolved in urine without the risk of urinary system obstruction.

FREE-STANDING BIODEGRADABLE PATCH

Methods and apparatus for a free-standing biodegradable patch suitable for medical applications, especially nasal applications are provided, wherein the patch comprises a free-standing film containing at least one therapeutic agent selected from corticosteroids, antihistamines, monoclonal antibodies, leukotriene receptor antagonists, anti-inflammatory cytokines, vasoconstrictive agents, and any combination thereof. The patch may take a non-adherent form during delivery to a target location within a vessel or tissue, and thereafter may be activated to adhere to vessel wall or tissue, and release the therapeutic content in a sustained fashion. The patch may be micronized and administered in a powdered form.